Copyright
©The Author(s) 2016.
World J Hepatol. Jul 18, 2016; 8(20): 850-857
Published online Jul 18, 2016. doi: 10.4254/wjh.v8.i20.850
Published online Jul 18, 2016. doi: 10.4254/wjh.v8.i20.850
Table 1 Characteristics of the 81 patients treated with transjugular intrahepatic portosystemic shunt + stomach and esophageal variceal embolization
| No. of patients | 81 (%) |
| Men | 63 (77.8) |
| Female | 9 (22.2) |
| Age (yr) | |
| Mean ± SD | 50.9 ± 10.9 |
| Range | 25-76 |
| Cause of liver disease | n (%) |
| Viral | 61 (75.4) |
| Alcoholic | 7 (8.7) |
| Viral and alcoholic | 1 (1.2) |
| Primary biliary cirrhosis | 4 (4.9) |
| Autoimmune hepatitis | 1 (1.2) |
| Cryptogenic | 7 (8.6) |
| Child-Pugh class | n (%) |
| A | 15 (18.5) |
| B | 47 (58.0) |
| C | 19 (23.5) |
| Endoscopic findings | |
| IGV1 | 25 (30.9) |
| GOV1 | 10 (12.3) |
| GOV2 | 46 (56.8) |
| Pre-PPG (mmHg) | |
| Mean ± SD | 38.0 ± 6.4 |
| Range | 26.0-48.0 |
| Follow-up (mo) | |
| Mean ± SD | 7.87 ± 5.57 |
| Range | 1-18 |
- Citation: Jiang Q, Wang MQ, Zhang GB, Wu Q, Xu JM, Kong DR. Transjugular intrahepatic portosystemic shunt combined with esophagogastric variceal embolization in the treatment of a large gastrorenal shunt. World J Hepatol 2016; 8(20): 850-857
- URL: https://www.wjgnet.com/1948-5182/full/v8/i20/850.htm
- DOI: https://dx.doi.org/10.4254/wjh.v8.i20.850